GENUINE FIRST AID INDUSTRIAL FIRST AIDÂ
aspirin, acetaminophen, ibuprofen, bacitracin zinc, neomycin sulfate, polymyxin b, benzalkonium chloride, lidocaine, benzalkonium chloride kit |
| Product Information |
| Product Type | HUMAN OTC DRUG | Item Code (Source) | NDC:52124-4016 |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC:52124-4016-6 | 1 in 1 KIT | | |
|
| Quantity of Parts |
| Part # | Package Quantity | Total Product Quantity |
| Part 1 | 10 PACKAGE | 8.0Â mL |
| Part 2 | 6 PACKET | 5.4Â g |
| Part 3 | 6 TUBE | 3.0Â g |
| Part 4 | 1 PACKET | 2Â |
| Part 5 | 1 PACKAGE | 2Â |
| Part 6 | 1 PACKAGE | 2Â |
|
| Part 1 of 6 |
ANTISEPTICÂ
benzalkonium chloride swab |
|
| Product Information |
| Item Code (Source) | NDC:52124-0001 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) | BENZALKONIUM CHLORIDE | 1.3 mg  in 1 mL |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | Â |
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC:52124-0001-1 | 0.8 mL in 1 PACKAGE | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph not final | part333A | 04/23/2010 | |
|
| Part 2 of 6 |
GENUINE FIRST AID BURN ANTISEPTIC PAIN RELIEF WITH ALOEÂ
benzalkonium chloride, lidocaine cream |
|
| Product Information |
| Item Code (Source) | NDC:52124-0004 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7) (BENZALKONIUM - UNII:7N6JUD5X6Y) | BENZALKONIUM CHLORIDE | 0.13 g  in 100 g |
| LIDOCAINE HYDROCHLORIDE (UNII: V13007Z41A) (LIDOCAINE - UNII:98PI200987) | LIDOCAINE HYDROCHLORIDE | 0.5 g  in 100 g |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| ALOE VERA LEAF (UNII: ZY81Z83H0X) | Â |
| CETYL ALCOHOL (UNII: 936JST6JCN) | Â |
| DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4) | Â |
| EDETATE DISODIUM (UNII: 7FLD91C86K) | Â |
| GLYCERIN (UNII: PDC6A3C0OX) | Â |
| GLYCERYL MONOSTEARATE (UNII: 230OU9XXE4) | Â |
| METHYLPARABEN (UNII: A2I8C7HI9T) | Â |
| MINERAL OIL (UNII: T5L8T28FGP) | Â |
| POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A) | Â |
| PROPYLENE GLYCOL (UNII: 6DC9Q167V3) | Â |
| PROPYLPARABEN (UNII: Z8IX2SC1OH) | Â |
| WATER (UNII: 059QF0KO0R) | Â |
| STEARIC ACID (UNII: 4ELV7Z65AP) | Â |
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC:52124-0004-1 | 0.9 g in 1 PACKET | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part333A | 04/13/2011 | |
|
| Part 3 of 6 |
GENUINE TRIPLE ANTIBIOTICÂ
bacitracin zinc,neomycin sulfate,polymyxin b sulfate ointment |
|
| Product Information |
| Item Code (Source) | NDC:52124-0003 |
| Route of Administration | TOPICAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| BACITRACIN ZINC (UNII: 89Y4M234ES) (BACITRACIN - UNII:58H6RWO52I) | BACITRACIN ZINC | 400 [iU]  in 1 g |
| NEOMYCIN SULFATE (UNII: 057Y626693) (NEOMYCIN - UNII:I16QD7X297) | NEOMYCIN SULFATE | 5 mg  in 1 g |
| POLYMYXIN B SULFATE (UNII: 19371312D4) (POLYMYXIN B - UNII:J2VZ07J96K) | POLYMYXIN B SULFATE | 5000 [iU]  in 1 g |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| WATER (UNII: 059QF0KO0R) | Â |
|
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC:52124-0003-1 | 0.5 g in 1 TUBE | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part333B | 04/13/2011 | |
|
| Part 4 of 6 |
IBUPROFENÂ
ibuprofen tablet |
|
| Product Information |
| Item Code (Source) | NDC:52124-0009 |
| Route of Administration | ORAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| IBUPROFEN (UNII: WK2XYI10QM) (IBUPROFEN - UNII:WK2XYI10QM) | IBUPROFEN | 200Â mg |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| POWDERED CELLULOSE (UNII: SMD1X3XO9M) | Â |
| STARCH, CORN (UNII: O8232NY3SJ) | Â |
| HYPROMELLOSES (UNII: 3NXW29V3WO) | Â |
| LACTOSE (UNII: J2B2A4N98G) | Â |
| MAGNESIUM STEARATE (UNII: 70097M6I30) | Â |
| POLYDEXTROSE (UNII: VH2XOU12IE) | Â |
| POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A) | Â |
| POVIDONE (UNII: FZ989GH94E) | Â |
| SILICON DIOXIDE (UNII: ETJ7Z6XBU4) | Â |
| STEARIC ACID (UNII: 4ELV7Z65AP) | Â |
| TITANIUM DIOXIDE (UNII: 15FIX9V2JP) | Â |
| TRIACETIN (UNII: XHX3C3X673) | Â |
|
| Product Characteristics |
| Color | white (White) | Score | no score |
| Shape | ROUND | Size | 10mm |
| Flavor | | Imprint Code |
44;352
|
| Contains | Â Â Â Â |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC:52124-0009-1 | 2 in 1 PACKET | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| ANDA | ANDA075010 | 02/17/2010 | |
|
| Part 5 of 6 |
NON-ASPIRIN
Â
acetaminophen tablet |
|
| Product Information |
| Item Code (Source) | NDC:52124-0010 |
| Route of Administration | ORAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) | ACETAMINOPHEN | 325Â mg |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| STARCH, CORN (UNII: O8232NY3SJ) | Â |
| POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A) | Â |
| STEARIC ACID (UNII: 4ELV7Z65AP) | Â |
| POVIDONE (UNII: FZ989GH94E) | Â |
|
| Product Characteristics |
| Color | white (White) | Score | no score |
| Shape | ROUND | Size | 11mm |
| Flavor | | Imprint Code |
AZ;234
|
| Contains | Â Â Â Â |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC:52124-0010-1 | 2 in 1 PACKAGE | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph not final | part343 | 04/23/2010 | |
|
| Part 6 of 6 |
ASPIRINÂ
aspirin tablet |
|
| Product Information |
| Item Code (Source) | NDC:52124-0011 |
| Route of Administration | ORAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| ASPIRIN (UNII: R16CO5Y76E) (ASPIRIN - UNII:R16CO5Y76E) | ASPIRIN | 325Â mg |
|
| Inactive Ingredients |
| Ingredient Name | Strength |
| HYPROMELLOSES (UNII: 3NXW29V3WO) | Â |
| POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A) | Â |
| PROPYLENE GLYCOL (UNII: 6DC9Q167V3) | Â |
| STARCH, CORN (UNII: O8232NY3SJ) | Â |
|
| Product Characteristics |
| Color | white (White) | Score | no score |
| Shape | ROUND | Size | 11mm |
| Flavor | | Imprint Code |
44;157;ASPIRIN
|
| Contains | Â Â Â Â |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC:52124-0011-1 | 2 in 1 PACKAGE | | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part343 | 04/23/2010 | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC monograph final | part333E | 05/03/2011 | |
|